The Nansen Neuroscience Network is being spearheaded by the University of Oslo’s Centre for Molecular Biology and Neuroscience (CMBN) and MI Lab in Trondheim with support from Innovation Norway. It can claim particular strengths in brain physiology, in vivo neuroimaging, memory and cognitive functions, biomarkers and preventive medicine.
Understanding the intricate workings of the brain and the central nervous system (CNS) is one of the greatest challenges to modern science and medicine, key to a greater understanding of the human organism and its complex structure. The Centre for Molecular Biology and Neuroscience (CMBN), a Norwegian Centre of Excellence appointed by the Research Council of Norway, is a cooperative effort jointly located at the University of Oslo and the Oslo University Hospital (Rikshospitalet).
The Oslo-based Centre has an international outlook with a clear mission to maintain a leading role to illuminate, characterize and interpret the role of DNA repair and genome maintenance mechanisms in preventing neurological disease, CNS infections and brain ageing. The Centre will develop and apply stem cell technology and targeted repair to broaden the range of therapeutic strategies in neurological disease.
According to Professor Tone Tønjum, Director of CMBN, “Over the past few years there has been an explosive increase in knowledge about the brain and the nervous system structure and function, and about the different diseases, and Norway has played a positive role in this research.” Close cooperation between the Centre´s 11 research groups at the University of Oslo and Oslo University Hospital is an integral element of all activities undertaken. Nearly 200 researchers are involved, including a number of international guest scientists providing a highly dynamic and innovative environment at the CMBN.